Unveiling potential diagnostic, treatment target for APS-rel

No standard treatment exists for thrombocytopenia in patients with antiphospholipid syndrome, but this could change with a new treatment target

Related Keywords

Ann Arbor , Michigan , United States , California , San Diego , Minnesota , Katarina Kmetova , Yu Zuo , Garyl Norman , Asraz Ahmed , D Srilakshmi Yalavarthi , Cyrus Sarosh , Cynthias Crowson , Noahf Peters , Ray Zuo , Gabriel Fiueroa Parra , Christinee Rysengas , Johanne Gudjonsson , Claire Hoy , Ali Duarte , Sherwina Navaz , Dava Nelson , Valerie Goodwin , Somanathapurak Naveenkumar , Jacquelinea Madison , Tristin Smith , J Michelle Kahlenberg , Kavya Sugur , Jasons Knight , Jennifer Girard , Emily Chong , University Of Michigan , Research Labs , Division Of Hematology , Department Of Internal Medicine , Division Of Rheumatology , Department Of Dermatology , Technology Center , University Of Michigan Health , Michigan Health , Early Career Professor , Mayo Clinic , Srilakshmi Yalavarthi , Internal Medicine , Newswise , Asic Science And Laboratory Research Antiphospholipid Syndrome Calprotectin Thrombocytopenia , All Journal News , Flood , Healthcare , Patient Safety , Ichigan Medicine University Of Michigan ,